[1]
|
K. J. Ryan and C. G. Ray, “Sherris Medical Microbiology,” 4th Edition, McGraw-Hill, New York, 2004.
|
|
[2]
|
N. Cimolai, “MRSA and the Environment: Implications for Comprehensive Control Measures,” European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology, Vol. 27, No. 7, 2008, pp. 481-493.
http://dx.doi.org/10.1007/s10096-008-0471-0
|
|
[3]
|
B. T. Cenci-Goga, M. Karama, P. V. Rossitto, R. A. Morgante and J. S. Cullor, “Enterotoxin Production by Staphylococcus aureus Isolated from Mastitic Cows,” Journal of Food Protection, Vol. 66, No. 9, 2003, pp. 1693-1696.
|
|
[4]
|
H. F. Chambers and F. R. DeLeo, “Waves of Resistance: Staphylococcus aureus in the Antibiotic Era,” Nature Reviews Microbiology, Vol. 7, No. 9, 2009, pp. 629-641.
http://dx.doi.org/10.1038/nrmicro2200
|
|
[5]
|
A. Clauditz, A. Resch, K. P. Wieland, A. Peschel and F. G?tz, “Staphyloxanthin Plays a Role in the Fitness of Staphylococcus aureus and Its Ability to Cope with Oxidative Stress,” Infection and Immunity, Vol. 74, No. 8, 2006, pp. 4950-4953.
http://dx.doi.org/10.1128/IAI.00204-06
|
|
[6]
|
M. Aires De Sousa and H. De Lencastre, “Bridges from Hospitals to the Laboratory: Genetic Portraits of Methicillin-Resistant Staphylococcus aureus Clones,” FEMS Immunology and Medical Microbiology, Vol. 40, No. 2, 2004, pp. 101-111.
http://dx.doi.org/10.1016/S0928-8244(03)00370-5
|
|
[7]
|
T. Ito and K. Hiramatsu, “Acquisition of Methicillin Resistance and Progression of Multi Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus,” YMJ: Yonsei Medical Journal, Vol. 39, 1998, pp. 526-533.
|
|
[8]
|
K. Sieradzki and A. Tomasz, “Inhibition of Cell Wall Turnover and Autolysis by Vancomycin in a Highly Vancomycin-Resistant Mutant of Staphylococcus aureus,” Journal of Bacteriology, Vol. 179, No. 8, 1997, pp. 2557-2566.
|
|
[9]
|
G. A. J. Ayliffe, W. Brumfitt, M. W. Caewell, B. D. Cookson and G. Duckworth, “Working Party Report— Revised Guidelines for Control of Epidemic Methicillin-Resistant Staphylococcus aureus,” Journal of Hospital Infection, Vol. 16, 1990, pp. 351-377.
http://dx.doi.org/10.1016/0195-6701(90)90008-C
|
|
[10]
|
I. M. Malonza, M. A. Omari, J. J. Bwayo, A. K. Mwatha, A. N. Mutere, E. M. Murage and J. O. Ndinya-Achola, “Community Acquired Bacterial Infections and Their Antimicrobial Susceptibility in Nairobi, Kenya,” East African Medical Journal, Vol. 74, No. 3, 1997, pp. 166-170.
|
|
[11]
|
S. I. Smith, B. Opere, H. T. Goodluck, O. T. Akindolire, A. Folaranmi, O. M. Odekeye and E. A. Omonigbehin “Antibiotic Susceptibility Pattern of Staphylococcus Species Isolated from Telephone Receivers,” Singapore Medical Journal, Vol. 50, No. 2, 2009, pp. 208-211.
|
|
[12]
|
A. M. Al-Mohana, A. H. Al-Charrakh, F. H. Nasir and M. K. Al-Kudhairy, “Community Acquired Methicillin-Resistant Staphylococcus aureus Carrying MecA and Panton Valentine leukocidin (PVL) Genes Isolated from the Holy Shrine in Najaf, Iraq,” Journal of Bacteriology Research, Vol. 4, No. 2, 2012, pp. 15-23.
|
|
[13]
|
A. Gandara, L. C. Mota, C. Flores, H. R. Perez, C. F. Green and S. G. S Gibb, “Isolation of Staphylococcus aureus and Antibiotic-Resistant Staphylococcus aureus from Residential Indoor Bioaerosols,” Environmental Health Perspectives, Vol. 114, No. 12, 2006, pp. 1859-1864.
|
|
[14]
|
P. Dufour, Y. Gillet, M. Bes, G. Lina, F. Vandenesch, D. Floret, J. Etienne and H. Richet, “Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in France: Emergence of a Single Clone that Produces Panton-Valentine Leukocidin,” Clinical Infectious Diseases, Vol. 35, 2002, pp. 819-824.
http://dx.doi.org/10.1086/342576
|
|